Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 10Myelodysplastic Syndromes 4Mycoses 4Hematologic Neoplasms 4Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Mucormycosis 1Leukemia, Myeloid 1Invasive Fungal Infections 1Genetic Predisposition to Disease 1Candidiasis 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Neoplasms 1Bone Marrow Failure Disorders 1Aspergillosis 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 44fludarabine phosphate 39Peripheral Blood Stem Cell Transplantation 36Busulfan 33Antilymphocyte Serum 26Cyclosporine 25Tacrolimus 24Filgrastim 23Mycophenolic Acid 22Methotrexate 22Radiotherapy 21Melphalan 16Etoposide 15Cytarabine 15Whole-Body Irradiation 14Methylprednisolone 13Cord Blood Stem Cell Transplantation 12Biopsy 8Azacitidine 8Sirolimus 7Flow Cytometry 7Cyclosporins 7Alemtuzumab 7Thiotepa 6Specimen Handling 6Psychiatric Rehabilitation 6Decitabine 6sargramostim 5ruxolitinib 5Rituximab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic-Myeloproliferative Diseases × posaconazole × Other hematologic neoplasm × Clear all
NCT04771130 2026-04-23

A Study of BGB-11417 in Participants With Myeloid Malignancies

BeOne Medicines

Phase 1/2 Recruiting
260 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡